Verification of Acuros XB dose algorithm using 3D printed low‐density phantoms for clinical photon beams by Zavan, Rodolfo et al.




Verification of Acuros XB dose algorithm using 3D










Washington University School of Medicine in St. Louis
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Zavan, Rodolfo; McGeachy, Philip; Madamesila, Joseph; Villarreal-Barajas, Jose-Eduardo; and Khan, Rao, ,"Verification of Acuros XB




R AD I A T I ON ONCO LOG Y PH Y S I C S
Veriﬁcation of Acuros XB dose algorithm using 3D printed
low-density phantoms for clinical photon beams
Rodolfo Zavan1 | Philip McGeachy1 | Joseph Madamesila1 |
Jose-Eduardo Villarreal-Barajas1 | Rao Khan2
1Department of Medical Physics, Tom
Baker Cancer Center, Calgary, AB, Canada
2Department of Radiation Oncology,
Washington University School of Medicine,
St. Louis, MO, USA
Author to whom correspondence should be
addressed. Philip McGeachy
E-mail: phil.mcgeachy@gmail.com
Telephone: +1 403 521 3790
Abstract
The transport-based dose calculation algorithm Acuros XB (AXB) has been shown to
accurately account for heterogeneities primarily through comparisons with Monte
Carlo simulations. This study aims to provide additional experimental veriﬁcation of
AXB for clinically relevant ﬂattened and unﬂattened beam energies in low density
phantoms of the same material. Polystyrene slabs were created using a bench-top
3D printer. Six slabs were printed at varying densities from 0.23 to 0.68 g/cm3, cor-
responding to different density humanoid tissues. The slabs were used to form dif-
ferent single and multilayer geometries. Dose was calculated with EclipseTM AXB
11.0.31 for 6MV, 15MV ﬂattened and 6FFF (ﬂattening ﬁlter free) energies for ﬁeld
sizes of 2 9 2 and 5 9 5 cm2. EBT3 ﬁlm was inserted into the phantoms, which
were irradiated. Absolute dose proﬁles and 2D Gamma analyses were performed for
96 dose planes. For all single slab conﬁgurations and energies, absolute dose differ-
ences between the AXB calculation and ﬁlm measurements remained <3% for both
ﬁelds in the high-dose region, however, larger disagreement was seen within the
penumbra. For the multilayered phantom, percentage depth dose with AXB was
within 5% of discrete ﬁlm measurements. The Gamma index at 2%/2 mm averaged
98% in all combinations of ﬁelds, phantoms and photon energies. The transport-
based dose algorithm AXB is in good agreement with the experimental measure-
ments for small ﬁeld sizes using 6MV, 6FFF and 15MV beams adjacent to various
low-density heterogeneous media. This work provides preliminary experimental
grounds to support the use of AXB for heterogeneous dose calculation purposes.
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1 | INTRODUCTION
Radiation therapy relies on accurate patient dose planning and deliv-
ery to ensure that the patient receives the prescribed dose. With
the development of treatment planning systems, fast and accurate
algorithms are available for dose calculation. The recently introduced
volumetric dose calculation algorithm Acuros XB (AXB) (Varian Medi-
cal Systems, Palo Alto, CA, USA) deterministically solves the linear
Boltzmann Transport Equation (LBTE).1–3 This new algorithm distin-
guishes itself from other methods of dose computation, such as the
Analytical Anisotropic Algorithm (AAA)4–6 and the Collapsed Cone
Convolution (CCC) algorithm, by directly solving the LBTE compared
to the convolution and superposition methods employed by AAA
and CCC to calculate dose. The LBTE describes the macroscopic
behavior of the radiation as it interacts with matter, such as the dose
deposition over a spatial resolution of roughly 1 mm or greater. AXB
approaches the LBTE by discretizing the variables in space, angle
and energy and iteratively solves for the ﬂuence. Dose in a voxel
can be calculated by using an energy-dependent response function
based on either dose-to-water or the material properties of the
voxel. Similar to the Monte Carlo method, AXB is capable of report-
ing dose using this dose-to-medium option. Unlike convolution and
superposition algorithms (e.g., AAA, CCC), where the heterogeneities
within a patient are handled using density-based corrections to the
dose kernels calculated in water, AXB explicitly models physical
interactions with matter using the mass density and material type
for each voxel of the CT dataset.
Acuros XB has previously been investigated and validated with
Monte Carlo simulations (VMC++, EGS4 etc) in heterogeneous
geometries2,7,8 and compared with other dose calculation algo-
rithms.9 Inhomogeneities have been simulated in varying complexity
in terms of geometry, density, and material compositions for differ-
ent ﬁeld sizes and energies.3 In most of these cases Monte Carlo
simulations, which is generally considered the gold standard in dose
calculation, were used as the main reference for the algorithm vali-
dation. In general, AXB provides a fast and accurate alternative to
Monte Carlo calculations for patient dose calculation. This has been
demonstrated by good Gamma agreement (>86% pass rates for 3%/
3 mm) for heterogeneous settings (normal lung, very low density
lung, and bone) when compared with MC calculations, and as an
improvement over AAA in terms of improved accuracy and reduced
computation time for lung VMAT plans.
To date, only a handful of experimental investigations validating
AXB in different geometric scenarios and clinical setups have been
conducted.1,3,10–14 The majority of studies involved comparing AXB
calculated dose results with commonly used clinical algorithms: AAA
and CCC methods. Kan et al. assessed the dosimetric impact of AXB
on intensity modulated radiotherapy (IMRT) and RapidArcTM for
locally persistent nasopharyngeal carcinoma when recalculated from
AAA.15,16 In this study, measurements were obtained using thermo-
luminescent dosimeters (TLDs) and an ionization chamber at discrete
points. Han et al. used the Radiological Physics Centre (RPC) head
and neck (H&N)17 and thorax phantom18 to evaluate AXB for IMRT
and volume modulated arc therapy (VMAT), using TLDs and Gaf-
Chromic EBT2 ﬁlm to obtain absolute point dose and planar dose
measurements, respectively. Furthermore, the majority of studies
were limited to only using 6MV beam energy. The present investiga-
tion looks to provide much needed data on experimental validation
of AXB for a variety of clinically relevant beam energies, particularly
in the case of lung VMAT and SBRT treatments, in a variety of
3D-printed, low-density geometries.
Published dosimetric comparisons have shown that the main
advantage of AXB is accurate dose calculation in low-density tis-
sues.2,18–20 Since AXB uses a density-to-material mapping table, it
would be prudent to verify the algorithm experimentally in the range
of both high- and low-density tissues. To experimentally validate the
algorithm in both density ranges, phantoms need to be fabricated
with the same tissue equivalent materials. In this work, we have
investigated only the low-density range for clinical energies of inter-
est in the small ﬁeld sizes, due to inherent limitations of the 3`D
printing fabrication process employed. That said, the investigation of
small ﬁeld size and low-density tissue range for AXB validation is of
clinical relevance as these conditions are akin to those of lung SBRT
treatments, which has been a topic of interest with respect to the
application of AXB.21–25
To this end, we have designed and developed phantoms of con-
sistent material composition but with variable densities using a desk-
top 3D printer. In the context of inhomogeneities in treatment
planning algorithms, dosimetric scalability (via methods such as
equivalent path length) and their validation is of particular interest.
To our knowledge, there is no economical and commercial equiv-
alent of variable density plastics available in the market. This work
looks to supplement the Monte Carlo validation of the AXB algo-
rithm performed thus far, with experimental evidence for a variety
of clinically relevant photon energies, in small ﬁelds and low-density
phantoms. This work is also unique in the dosimetric applicability of
cost-effective 3D desktop printing in a cancer centre.
2 | MATERIALS AND METHODS
2.A | Experimental setup and geometry
Phantom slabs were created for this study using a 3D printer ORION
Delta 3D (SeeMeCNC; Ligonier, IN, USA). ORION is a Rostock delta-
style printer consisting of three motorized controlled arms to provide
full motion of fabrication along three orthogonal directions. The
phantom slabs were fabricated with the purpose of varying the mass
density while maintaining chemical composition, using only low
atomic number elements common to human tissue. Polystyrene slabs
of 10 9 10 9 2.4 cm3 were 3D printed, varying the printing param-
eters to roughly mimic the composition and density range of lung
tissue.26 For all of 3D printed objects in this study, we restricted the
inﬁll pattern to the default grid pattern. For every slab, the quality of
printing was veriﬁed with subsequent computed tomography (CT)
scans acquired with 3 mm slice thicknesses. The mass density was
determined from Hounsﬁeld-Unit-to-density calibration. The quality
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of each print was evaluated by reviewing CT images to ensure a uni-
form and artifact-free object interior. The orientation of each test
slab was labelled for reproducibility and alignment between the sim-
ulation and the irradiation.
Each polystyrene slab was surrounded by 4 cm of Solid WaterTM
(Gammex-RMI, Middleton, WI, USA) above and 5 cm below. Custom-
cut Perspex sheets were used to surround the slab laterally to
minimize air gaps between layers. Figure 1 shows a schematic repre-
sentation of the phantom setup for two geometries tested: single-slab
and multiple-slabs. For the single-slab, GafChromic EBT3 (Ashland
Advanced Materials, Bridgewater, NJ, USA) ﬁlms were placed above
(depth P in Fig. 1) and below (depth Q in Fig. 1) the polystyrene slab.
Variable density slabs were swapped to create 6 single-slab phantom
conﬁgurations. For the multi-slab phantom, slabs 3, 6, and 4 (Table 1)
were stacked with the ﬁlms placed above, below and between each of
the layers of polystyrene (depths A through D in Fig. 1). All seven
phantoms were CT-scanned with a 3 mm slice thickness.
2.B. | Dose calculation and measurements
The CT datasets were imported into EclipseTM (Varian Medical Sys-
tem) treatment planning system, and dose calculations were per-
formed for 6MV, 6FFF (6MV Flattening Filter Free) and 15MV
beams from a Varian TrueBeamTM linear accelerator. The irradiations
were planned for ﬁeld sizes of 2 9 2 cm2 and 5 9 5 cm2 with
source-to-surface distance (SSD) set to 100 cm. These smaller, clini-
cally-relevant ﬁeld sized are typical of lung SBRT treatments, where
we would expect more challenges for the dose calculation accuracy
in low-density media. A dose of 200 cGy was planned to a 4 cm
depth (Fig. 1 depth P).
From the previous AXB studies,1,3,10–14 most of the institutions
used a default dose grid of 2.5 mm for dose computation, therefore
a calculation grid size of 2.5 mm was chosen for the AXB dose cal-
culations with dose reported as dose-to-medium. AXB can also
report dose-to-water; however, it was not pursued in our study.27
The decision of reporting dose-to-water or dose-to-medium has
been a point of discussion in the past and justiﬁcation of our choice
in this study is provided in Discussion. No volume of the radiation
ﬁeld was allowed to travel through the lateral Perspex.
(a)
(b) (c)
F I G . 1 . (a) Layout of the phantoms
shown in axial view. Left: the single slab
phantom geometry. Right: the multi slab
phantom geometry. (b) Stack of solid water
slabs used with 3D printed slabs. (c) 3D
printed phantom with surrounding acrylic
for centering and scattering purposes.
TA B L E 1 Mass density of the 3D-printed polystyrene slabs. “SD”
represents one standard deviation over the volume of the slab.
Mean density (g/cm3) Mean HU  SD
Slab 1 0.37 645  5
Slab 2 0.30 713  7
Slab 3 0.51 502  6
Slab 4 0.23 785  23
Slab 5 0.61 391  10
Slab 6 0.68 330  10
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For a single slab phantom of low-density 0.23 g/cm3 (Slab 4),
dose was also computed with the commonly available AAA. Dose
planes were extracted both at depths P and Q for the three energies
and both ﬁeld sizes.
All ﬁlms and fabricated plastic slabs were aligned using external
ﬁducial markings (BBs), placed on the phantom before CT simulation.
The irradiations were done for all six single slab phantom setups and
the multi-slab setup, for two radiation ﬁelds and three beam energies
with radiochromic ﬁlms placed as shown in Fig. 1. Prior to each irra-
diation, the output of the linear accelerator was veriﬁed with an ion-
ization chamber in a SolidWaterTM phantom. The ionization chamber
calibration is traceable to a primary standard at NRCC (National
Research Council of Canada).
2.C | Film dosimetry
GafChromic EBT3 ﬁlm, which was designed for clinical dosimetry,
was used in all of the studies. Small (4 9 4 cm2) EBT3 ﬁlm calibra-
tion strips from the same batch were cut and marked for orientation.
The ﬁlms were reproducibly placed in a plastic template and scanned
using an EPSON Expression 10000 XL ﬂatbed scanner (US Epson,
Long Beach, CA, USA). The ﬁlms were scanned with transmission
mode (positive ﬁlm mode), 48 bits RGB (16 bits per channel color),
72 dpi resolution (0.35 mm/pixel), without any image correction. The
GafChromic EBT3 ﬁlm response is independent of energy for the
range of MV photon energies investigated in this study.
The calibration ﬁlm strips were placed at a depth of 5 cm in a
30 9 30 9 20 cm3 SolidWaterTM phantom and irradiated with a
6MV linac beam for doses ranging from 0 to 8 Gy at 600 MU/min.
The dose was subsequently measured in the same phantom at 5 cm
depth with a calibrated ionization chamber traceable to the NRCC.
The dose-to-water at 5 cm depth was determined from ionization
measurements and using cross-calibration factors related to absolute
dosimetry using AAPM TG51 protocol guidelines.
All calibration ﬁlm strips were scanned as previously described at
the same location on the scanner, 24  4 h after irradiation to ensure
the optical density of the polymerized ﬁlm has stabilized. Pre-irradia-
tion images were used to account for zero dose background intensity.
The corrected images of all the strips were imported in the calibration
module of DoseLab Pro version 6.50 (Mobius Medical Systems LP,
Houston, TX, USA). EBT3 exhibits highest sensitivity (higher absor-
bance) at 636 nm; therefore, for dose evaluation, the maximum sensi-
tivity is obtained using the red channel. According to the
manufacturer, the red channel is recommended for dose evaluations
up to 8 Gy. The resulting calibration plot was used for subsequent
dose conversion for all irradiated ﬁlms. More details about our ﬁlm
dosimetry protocol can be found in the literature.28
2.D | Planar dosimetric comparison
For all experimental geometries, only one set of irradiations was per-
formed. In total, 96 dose planes, 72 for the single analysis and 24
for the multi-slab setup, calculated by Eclipse using AXB were
exported and compared with the ﬁlm measurements obtained from
the GafChromic EBT3 ﬁlms. We repeated irradiations for one conﬁg-
uration to verify the reproducibility. DoseLab Pro version 6.50 was
used to perform ﬁlm calibration and comparisons with calculated
dose planes. Two-dimensional local Gamma evaluation was per-
formed for each ﬁlm using 2% absolute dose and 2 mm distance-to-
agreement criteria with a 10% dose cutoff threshold.29
3. | RESULTS
Table 1 shows a summary of the physical properties of all printed
polystyrene blocks. Based on the Hounsﬁeld Unit (HU) of each
voxel, density and material assignments are performed by AXB Ver-
sion 11’s material library. The variation in HU was found to be
within 2-4% of the mean value for all the slabs of various physical
densities.
3.A | Single slab phantom measurements
Absolute dose proﬁles were extracted in the cross-plane direction
from the ﬁlms and compared with AXB calculated dose proﬁles for
all conﬁgurations of slabs, energies and ﬁeld sizes. Figures 2 and 3
show the proﬁles for the single slab phantom (density 0.68 g/cm3
[slab 6]) for ﬁeld sizes of 2 9 2 and 5 9 5 cm2, respectively. The
ratio of measured-to-calculated dose is also superimposed onto each
proﬁle. Dotted horizontal lines (3% relative error) are drawn for
guidance. All measurements and computations were found to be
within 3% of each other, excluding the 90–10% penumbra regions.
Absolute dose proﬁles were extracted from the ﬁlms at depth P
and Q for Slab 4 (slab with lowest available density of 0.23 g/cm3)
and compared with corresponding computed proﬁles from AAA and
AXB for the three energies and the 5 9 5 cm2 ﬁeld size. Figure 4
shows the absolute proﬁles and relative difference between compu-
tation and measurements. The results show that both algorithms
were within 3% of the ﬁlm measurements for all three energies in
the high-dose region.
For all planar doses, 2D Gamma analyses were performed.
Table 2 shows failure rates for each absolute 2D Gamma analysis
for 6MV, 6FFF and 15 MV beams and the stated 2%/2 mm criteria.
All measured Gamma data showed pass rates ranging from 96.7% to
100% for all three beam energies and both ﬁeld sizes at depths Q
and P in the single slab phantoms.
3.B | Multi-slab phantom measurements
Reasonable proﬁle agreement was observed at all depths in the mul-
ti-slab phantom to within 3% of computation. Table 2 also summa-
rizes the 2D Gamma analysis for the multi-slab phantom geometry
for all energies, ﬁeld sizes, and depths (A through D). As a whole, all
Gamma indices were able to achieve >95% pass rate with the major-
ity of indices exceeding a high pass rate of ~98% for 2%/2 mm eval-
uation criterion for all energies and both ﬁeld sizes in the multi-slab
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heterogeneous phantom. Using discrete ﬁlm measurements along
the central axis of the beam, a comparison was made with the com-
putation (Fig. 5). Error bars representing one standard deviation of
the mean of the region of interest around the central pixel are given
for each measurement.
4. | DISCUSSION
AAPM task group report (TG-65)30 on tissue heterogeneity manage-
ment in radiation therapy enlists many challenges, most notably
radiation transport through bone, air passages, cavities, and lung.
With the exception of Monte Carlo simulation of radiation transport,
modeling multiple scattered photons and high-energy electrons
remains difﬁcult for most of the treatment planning algorithms used
today, especially for high-energy beams in low-density media.18,31
Introduction of the transport-based solver Acuros XB has provided
another venue to more accurately compute dose deposition in addi-
tion to Monte Carlo simulations. Adequately modeling primary beam
attenuation, scattering of photons and transport of high-energy elec-
trons as they pass through media of different densities and composi-
tions requires proper consideration of the physical properties of the
F I G . 2 . Absolute dosimetric proﬁle comparisons for the 0.68 g/cm3 density slab for 6MV (top), 6FFF (middle), and 15MV (bottom) energies
with 2 9 2 cm2 ﬁeld size for depths Q (left) and P (right).
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medium and its inﬂuence on radiation. AXB accurately models the
complex photon and electron transport in heterogeneous tissues by
explicitly taking into account the material type and chemical compo-
sition.4–6
Validation of this dose algorithm in heterogeneous regions is an
important task, and few studies have veriﬁed the algorithms through
measurements. Benchmarking of such algorithms is often performed
using Monte Carlo simulation with digital phantom geometries. The
previously reported experimental methods have been either limited
to point or relative measurements with different materials of variable
compositions,10–14 thereby restricting their use for testing an algo-
rithm which explicitly accounts for material compositions.
In the context of validating AXB, using phantoms of the same
material with varying densities is of critical importance due to the
algorithm’s ability to model inhomogeneities using material composi-
tion. This work is the only example where custom-built polystyrene
slabs have been created, providing consistent chemical composition
while allowing for variation in mass density. This was accomplished
by printing custom slabs with relatively new 3D printing technology.
Three-dimensional printing is igniting interest in many different areas
F I G . 3 . Absolute dosimetric proﬁle comparisons for the 0.68 g/cm3 density slab for 6MV (top), 6FFF (middle), and 15MV (bottom) energies
with 5 9 5 cm2 ﬁeld size at depths Q (left) and P.
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of radiotherapy such as the development of 3D printed electron
bolus.32 We have shown that a simple, inexpensive, and desktop-
based printer can fabricate uniform and homogeneous phantom
materials with minimal effort.26 However, one of the limitations of
the presented technique is the inability to print and fabricate high-
density humanoid tissue objects. The challenge is posed by the avail-
ability of high-density tissue equivalent plastic ﬁlaments. Though
there are a few high-density metal powders (iron, bronze, copper
etc) and plastic mix ﬁlaments available, their radiological properties
are quite different from bones and other high-density tissues. The
3D fabrication methodology employed in our work with typical
tissue equivalent plastics cannot exceed the density of the ﬁlament
employed. Therefore, our current investigation was limited to low-
density object fabrication and their use for dose algorithm validation
studies.
We experimentally tested the AXB in challenging geometries:
both small ﬁelds and low-density heterogeneous interfaces for 6MV,
6FFF and 15 MV clinical energies. The choice of energies in our
study was dictated by the TrueBeamTM conﬁguration available in our
case. We chose GafChromic EBT3 ﬁlms owing to their ﬂexibility, and
energy independence for MV dosimetry. Compared to ion chamber
point dose measurements, the ﬁlms provide higher spatial resolution
F I G . 4 . Absolute dosimetric proﬁle comparisons (AXB, AAA, and Film measurements) for a slab of density 0.23 g/cm3 for 6MV (top), 6FFF
(middle), and 15MV (bottom) energies with 5 9 5 cm2 ﬁeld size.
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and nondestructive, full dosimetric maps in a phantom. This was crit-
ical for the experimental validation performed in our study.
For the single slab phantom geometry (Fig. 2 and Table 2), excel-
lent agreement was found between AXB and the GafChromic ﬁlm
measurements for 5 9 5 cm2 beams, with relative dose error below
3%. This agrees with Han et al. who observed AXB calculations
matching discrete TLD measurements to within 5% using a RPC
Head and Neck phantom,17 and Rana et al., who reported differ-
ences in up to 3%10 (only 6MV beams were used in both studies).
For a small ﬁeld of 2 9 2 cm2, the agreement also remained within
3% of dose measurements close to the center axis of the beam,
deteriorating only in the penumbra region of the beam. Kan et al.16
investigated the differences in dose at distal interfaces using 6MV
beams and AXB for 2 9 2 cm2 ﬁelds and obtained differences in up
to 6% across media interfaces.15 AXB agreed with Monte Carlo sim-
ulated percent depth dose to within 2% in that study. Sato et al. also
studied AXB in the build-down region after lung-water interfaces
with a 4MV beam and 4 9 4 cm2 open ﬁelds, concluding the accu-
racy of AXB to be 3% when comparing with measurements and with
AAA.15 This is consistent with our measurements at depth Q, with
absolute dose agreement also within 3%. The 6FFF and 15MV
results cannot be compared to the literature due to a lack of small-
ﬁeld results for these beam energies in other studies. Bush et al.
found differences of up to 3% near heterogeneous lung interfaces
and up to 4.5% near air cavities.7 The data, however, were solely
obtained using Monte Carlo simulations with BEAMnrc /DOSXYZnrc
as a benchmark.
The major source of disagreement between ﬁlm measurements
and AXB calculations in our work arises in the penumbra regions in
both ﬁeld sizes for all energies. Since AXB models only the radiation
transport through the patient, a major component of dosimetric
penumbra depends on how the quality of the multisource model in
Eclipse compares to the user’s commissioning measurements, and
the size of the radiation detector used in acquiring commissioning
data. A beam model generates the fraction of primary and scatter
components of a linac beam as a result of an iterative optimization
process over a range of measured proﬁles at various depths. For a
given energy, the quality of the multisource model is a compromise
over all input proﬁles at ﬁeld sizes from 3 9 3 cm2 to 40 9 40 cm2
at various depths in a water phantom during the beam modeling and
conﬁguration. In the case of AXB, source size is the only variable
available to adjust the penumbra; the Beam Conﬁguration workspace
does not provide the ﬂexibility to allow for manual tweaking. The
secondary source distance in the modelling step can also have an
impact on the size of the penumbra. A coarse CT slice thickness of
3 mm parallel to the beam direction could also result in voxel aver-
aging for 3D printed low-density objects, especially in the penumbra.
Although strict alignment of printed slabs was observed between the
simulation and measurements, slight variations from setup to setup
could also result in disagreements, especially close to ﬁeld edges.
We used two tools for analysis: (1) The absolute dose proﬁles
along the cardinal axes and (2) planar dose comparison using 2D
Gamma analysis. The proﬁles require absolute alignment between
the measurement and computations. This method is affected by
TA B L E 2 Absolute 2D Gamma failure rates, 2%/2 mm criteria at depths P and Q for the single-layer conﬁguration, and depths A, B, C, and D
for the multi-layer conﬁguration.
Density (g/cm3)/Slab # Depth
6MV 6FFF 15MV
5 3 5 2 3 2 5 3 5 2 3 2 5 3 5 2 3 2
Single layer phantom conﬁguration
0.37/Slab 1 Q 0.2 0.0 1.0 0.0 0.3 0.2
P 0.3 0.0 3.3 0.0 1.7 0.0
0.30/Slab 2 Q 0.4 0.0 1.2 0.0 1.2 0.1
P 2.5 0.0 2.3 0.1 1.0 0.0
0.51/Slab 3 Q 0.5 0.0 0.3 0.0 0.6 0.0
P 0.7 0.9 0.4 0.0 0.4 0.0
0.23/Slab 4 Q 0.2 0.0 0.2 0.0 0.9 0.1
P 0.2 0.0 0.4 1.5 2.1 0.0
0.62/Slab 5 Q 0.5 0.0 0.4 0.0 0.2 0.0
P 0.5 0.0 0.3 0.0 1.7 0.1
0.68/Slab 6 Q 0.3 0.0 0.3 0.0 0.2 0.0
P 0.5 0.1 0.2 0.3 0.4 0.0
Multilayer phantom conﬁguration
A 0.9 1.4 0.1 2.0 0.1 0.0
B 0.1 4.2 1.5 0.4 0.0 0.0
C 2.0 0.1 2.9 1.8 2.7 0.0
D 0.9 2.3 0.6 0.0 0.7 1.7
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step-size resolution, especially in the penumbra, and suffers when
using the same evaluation criteria for the high-dose regions and
penumbra. Gamma analysis is somewhat forgiving in terms of align-
ment using distance to agreement along with the absolute doses.
The AAPM TG 53 report recommends a 3%/3 mm acceptance
criterion between calculated and measured dose distributions for
commissioning a treatment planning system.33 Two-dimensional
Gamma analysis with stricter criteria for open ﬁelds as a complement
to dose proﬁles should be used as a viable tool for commissioning
treatment planning systems. Therefore, 2D Gamma analysis was per-
formed throughout the study for all ﬁelds and energies using more
stringent Gamma criteria of 2%/2 mm for all single phantom mea-
surements. Except for a few instances (all data ranged from 96.7%
to 100% Gamma pass rates), our Gamma index analysis using the
aforementioned criteria resulted in a ~98% pass rate of pixels. Han
et al. also analyzed the Gamma index using Gamma criteria of 3%/
3 mm and obtained agreement of >97% of pixels using ﬁlm mea-
surements.14 However, Fogliata et al. calculated an average agree-
ment of 86% with 3%/3 mm adjacent to lung.2 In that study, 2D
Gamma analysis for VMC++ simulated data was done adjacent to
lung phantoms which is similar to the experimental setup used in
our study. Gamma analysis is a difﬁcult benchmark to compare with
other studies due to lack of standard evaluation criteria.29,34 Han
et al.17 used different criteria when analyzing the 2D Gamma index
such as 7%/4 mm, and considered the commonly used 3%/3 mm
criteria too strict for their purposes.
In addition to delivery uncertainties of about 2–3% in our phan-
tom irradiations, there are sources of uncertainty related to compu-
tational algorithms. In this study, AXB automatically assigned
different material types to each pixel of the phantom; the material
override feature was not considered. Therefore, for dose computa-
tion, density-to-material assignment for voxels of 3D printed slabs
resulted in using low-density lung, adipose tissue, muscle, and their
combinations as the material of the voxels. The slight difference in
chemical composition can produce a small disagreement. The auto-
assignment of materials represents the real clinical scenario—the
way AXB is designed for automatic voxel segmentation for biological
materials in patients. Comparison with dose-to-water reporting by
AXB was avoided in our studies. It has been shown that the conver-
sion of dose-to-medium to dose-to-water using stopping power
ratios, as computed by Monte Carlo and AXB, may be substantially
(up to 11%) different.27
In the multi-slab phantom conﬁguration, dose proﬁle agreement
is achievable within 3% of measurements at all depths. Table 2 lists
2D planar Gamma analysis for all energies and the two ﬁeld sizes; in
all cases 97.1–100% of points pass the Gamma criteria. This is a
strong indication of accurate modeling of radiation transport through
multi-density layers for the tested 6MV, 6FFF and 15 MV beams.
Central axis discrete depth dose (Fig. 6) show that the achievable
agreement is within 5%. This may be due to mixture voxels created
at each interface in the phantom and the coarse spacing of the dose
grid.35 The mixture voxels consisting of both air and plastic are
F I G . 5 . Planar gamma index for the
2 9 2 cm2 15MV beam (top) and
5 9 5 cm2 6FFF beam (bottom) at depths
Q (left) and P (right) with a slab of density
0.68 g/cm3.
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created along all interfaces between these materials. The voxel
material is an average of air to plastic contents available in a voxel.
The measured dose is systematically lower due to the formation of
an air gap for the shallow layer, resulting in a slight offset in the rest
of the interfaces.
Several sources of uncertainty need to be considered when
interpreting the ﬁlm measurements. In this study, all measurements
were performed using GafChromic ETB3 ﬁlms commissioned with an
inherent inaccuracy of 2%, which remains the main contributor to
uncertainties in the measurements.
TrueBeamTM output was recorded prior to measurements and the
variation was found to be <1% of the beam output. Uncertainties in
setup were thoroughly analyzed for potential variations between CT
simulation and actual radiation delivery. Dose planar measurements
were done above and below 3D printed slabs, which resulted in vari-
ous interfaces causing an uncertainty of about 2 mm due to the
reproducibility of setup. This can cause a dose variation of about 2%
at depths P and Q. Uncertainty due to SSD setup was determined to
be <1 mm. The 3D printed blocks can vary by as much as 0.5 mm
in thickness between each block, and has the potential for creating a
F I G . 6 . Central axis depth dose plots for the multi-slab geometry. Energies shown are 6MV (top), 6FFF (middle), and 15MV (bottom) for
ﬁeld sizes 5 9 5 cm2 (left) and 2 9 2 cm2 (right). Media used from left to right: Solid Water, slab 3 (0.51 g/cm2), slab 6 (0.68 g/cm2), slab 4
(0.23 g/cm2), and Solid Water. Discrete ﬁlm measurements are plotted. The error bars represent one standard deviation of the mean of an ROI
of 3 9 3-pixel width around the center. Color overlay of rectangular blocks approximately shows the various density slabs.
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small air gap adjacent to the upper interface at depth P. Each layer
of EBT3 ﬁlm is approximately 0.25 mm thick which can add up to
1 mm for a multi-slab phantom geometry. Table 3 provides a concise
summary and description of various sources of uncertainty.
Another source of uncertainty arises from overlapping dosimetric
quantities—dose-to-water, dose-to-medium and dose-to-plastic in
our experiments. The quantity measured with ﬁlm is dose-to-water,
which is obtained by converting optical density to dose. EBT3 ﬁlm is
known to be tissue equivalent in the Compton interaction range of
energies and low Zeff for the low-energy component of MV
photons.18,26,28 The treatment machine is calibrated in terms of
dose-to-water according to the national and international dosimetry
protocols. The differences between dose-to-water and dose to most
soft tissues are clinically insigniﬁcant (within 2%).31,36,37 The overall
uncertainty of all the setup and delivery, taken in quadrature (as in
Table 3), is estimated to be below 3%.
Through this work, we have provided an experimental framework
for validation of transport-based dose calculation in single-slab and
multi-slab low-density geometries for common clinical beam ener-
gies. By developing custom phantoms using materials tailored to
speciﬁc clinical needs, one can characterize the speciﬁc modeling
capabilities of new dose calculation engines.
5. | CONCLUSIONS
The advanced dose algorithm AXB was found to provide satisfactory
agreement with experimental measurements using 6MV and 15MV
ﬂattened photon beams, as well as for unﬂattened 6FFF beams in
low-density heterogeneous media. This work provides an experimen-
tal evaluation of AXB algorithm for dose calculations in the challeng-
ing scenario of small ﬁelds irradiating low-density regions, such as
lung and adipose tissue. This provides added conﬁdence in using this
dose calculation algorithm in clinically relevant scenarios, such as the
treatment of small lesions with relatively small ﬁeld sizes in regions
located at or in close proximity to soft tissue, low-density interfaces,
such as SBRT treatments for non-small cell lung cancer.
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